Charles Cherington - 13 Oct 2022 Form 4 Insider Report for Comera Life Sciences Holdings, Inc.

Role
10%+ Owner
Signature
/s/ Megan Foscaldi, as attorney in fact for the Reporting Person
Issuer symbol
CMRA on OTC
Transactions as of
13 Oct 2022
Net transactions value
+$17,387
Form type
4
Filing time
14 Oct 2022, 16:03:17 UTC
Previous filing
30 Sep 2022
Next filing
18 Oct 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CMRA Common Stock Purchase $17,387 +10,481 +1.7% $1.66 615,411 13 Oct 2022 Direct F1
holding CMRA Common Stock 1,268,761 13 Oct 2022 By LLC F2
holding CMRA Common Stock 95,328 13 Oct 2022 By trust F3
holding CMRA Common Stock 95,327 13 Oct 2022 By trust F4
holding CMRA Common Stock 95,328 13 Oct 2022 By trust F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The price reported in Column 4 is a weighted-average price. These shares were purchased in multiple transactions at prices ranging from $1.58 to $1.70 inclusive. The report person undertakes to provide to Comera Life Sciences Holdings, Inc. ("Comera"), any security holder of Comera, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote 1.
F2 Held by Cherington Holdings LLC, of which the reporting person is a partner.
F3 Held by Ashley S. Pettus 2012 Irrevocable Trust FBO Benjamin P. Cherington, of which the reporting person is trustee.
F4 Held by Ashley S. Pettus 2012 Irrevocable Trust FBO Cyrus B. Cherington, of which the reporting person is trustee.
F5 Held by Ashley S. Pettus 2012 Irrevocable Trust FBO Henry S. Cherington, of which the reporting person is trustee.